The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
In drug discovery, chemical genomics, or chemogenomics, involves screening chemical compounds against genes or gene products, such as proteins or other targets. Through this functional analysis, researchers hope to elicit gene response, tease out drug candidates, and identify and validate therapeutic targets.